|
시장보고서
상품코드
1831668
액체 색전제 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제품 유형별, 용도별, 최종 사용자별, 지역별, 예측(2025-2034년)Liquid Embolic Agent Market Size, Share, & Industry Analysis Report By Product Type (Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 액체 색전제 시장 규모는 2034년까지 6억 1,305만 달러에 이를 것으로 예측됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
액체 색전제는 뇌동정맥 기형, 동맥류 및 기타 혈관 이상을 치료하는 데 사용되는 낮은 침습 솔루션입니다. 이 색전제에는 에틸렌 비닐 알코올(EVOH) 공중합체, 시아노아크릴레이트계 접착제 및 기타 특수 색전 재료가 포함됩니다.
시장 성장의 원동력이 되는 것은 신경혈관 질환의 유병률의 상승, 인터벤셔널 신경 방사선과의 증가, 종래의 치료법에 대한 액체 색전제의 임상적 우위성 등입니다. 또한 지원 상환 정책, 규제 상황, 신경혈관 인터벤션 장치의 기술 혁신은 신경 인터벤션 치료의 전망을 재구성하고 있습니다.
액체 색전제 시장 보고서 하이라이트
제품 유형별로, 양호한 안전성 프로파일, 제어된 중합 공정 및 신경혈관 색전술에서 광범위한 사용으로 에틸렌 비닐 알코올(EVOH) 부문이 2024년 시장을 독점했습니다.
용도별로는 동정맥 기형(AVM) 분야가 2024년에 시장을 독점했습니다. 저침습 색전술의 채용이 증가하고 임상적 증거가 지지된 것이 요인입니다.
최종 사용자별로, 병원은 2024년에 가장 큰 시장 점유율을 차지했으며, 고급 신경 인터벤션 시설, 숙련된 전문의의 가용성, 유리한 보험 적용에 지원됩니다.
북미는 2024년에 액체 색전제 시장을 독점하여 강력한 규제 당국의 승인, 고급 건강 관리 인프라, 신경혈관 질환 환자의 대규모 기반에 밀어붙였습니다.
아시아태평양은 인지도 향상, 의료 투자 증가, 중국, 인도, 일본의 고급 색전술 채택으로 예측 기간 동안 가장 빠른 CAGR을 나타낼 것으로 예측됩니다.
세계 시장의 주요 기업은 Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Balt Group, Boston Scientific Corporation, Penumbra Inc., Merit Medical Systems Inc., Guerbet Group SA, Arsenal Medical Inc., Meril Life Sciences Pvt.등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 액체 색전제 시장 인사이트
- 시장 현황
- 액체 색전제 시장 역학
- 성장 촉진요인과 기회
- 신경질환 및 암 관련 혈관질환의 세계적 증가
- 정부의 의료비 지출과 선진 치료의 촉진 정책
- 억제요인과 과제
- 고액의 처치 비용과 숙련된 중재적 방사선과 의사의 부족
- 성장 촉진요인과 기회
- PESTEL 분석
- 액체 색전제 시장 동향
- 밸류체인 분석
제5장 세계의 액체 색전제 시장 : 제품 유형별
- 주요 조사 결과
- 소개
- 에틸렌비닐알코올 공중합체(EVOH)
- 시아노아크릴레이트(Cyanoacrylates)
- 기타 제품 유형
제6장 세계의 액체 색전제 시장 : 용도별
- 주요 조사 결과
- 소개
- 동정맥 기형(AVM)
- 다혈성 종양
- 말초 혈관 출혈
- 기타 용도
제7장 세계의 액체 색전제 시장 : 최종 사용자별
- 주요 조사 결과
- 소개
- 병원
- 전문 클리닉
- 외래수술센터(ASC)
- 기타 최종 사용자
제8장 세계의 액체 색전제 시장 : 지역별
- 주요 조사 결과
- 소개
- 액체 색전제 시장 평가 : 지역, 2020-2034년
- 북미
- 북미 : 제품 유형별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품 유형별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품 유형별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종 사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품 유형별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 프로파일
- Arsenal Medical Inc.
- Balt Group
- Boston Scientific Corporation
- Chemence Medical Inc.
- Guerbet Group SA
- Johnson & Johnson
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- Merit Medical Systems Inc.
- Penumbra Inc.
- Stryker Corporation
- Terumo Corporation
The liquid embolic agents market size is expected to reach USD 613.05 million by 2034, according to a new study by Polaris Market Research. The report "Liquid Embolic Agent Market Share, Size, Trends, Industry Analysis Report: By Product Type ((Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Liquid embolic agents are minimally invasive solutions used for the treatment of cerebral arteriovenous malformations, aneurysms, and other vascular abnormalities. These agents include ethylene vinyl alcohol (EVOH) copolymers, cyanoacrylate adhesives, and other specialized embolic materials.
Market growth is driven by the rising prevalence of neurovascular diseases, an expanding base of interventional neuroradiologists, and clinical advantages of liquid embolic agents over conventional treatments. Moreover, supportive reimbursement policies, regulatory clearances, and technological innovations in neurovascular intervention devices are reshaping the neurointerventional treatment landscape.
Liquid Embolic Agent Market Report Highlights
Based on product type, the ethylene vinyl alcohol (EVOH) segment dominated the market in 2024, driven by its favorable safety profile, controlled polymerization process, and widespread use in neurovascular embolization.
In terms of application, the arteriovenous malformations (AVMs) segment dominated the market in 2024, fueled by rising adoption of minimally invasive embolization procedures and supportive clinical evidence.
Based on end user, the hospitals accounted for the largest market share in 2024, supported by advanced neurointerventional facilities, availability of skilled specialists, and favorable insurance coverage.
North America dominated the liquid embolic agents market in 2024, fueled by strong regulatory approvals, advanced healthcare infrastructure and a large base of neurovascular disease patients.
Asia Pacific is projected to record the fastest CAGR during the forecast period, driven by increasing awareness, growing healthcare investments, and adoption of advanced embolization procedures across China, India, and Japan.
Key players in the global market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Balt Group, Boston Scientific Corporation, Penumbra Inc., Merit Medical Systems Inc., Guerbet Group S.A., Arsenal Medical Inc., Meril Life Sciences Pvt. Ltd., and Chemence Medical Inc.
Polaris Market Research has segmented the market report based on product type, application, end user, and region:
By Product Type Outlook (Revenue, USD Million, 2020-2034)
Ethylene Vinyl Alcohol Copolymer (EVOH)
Cyanoacrylates
N-BCA (n-Butyl Cyanoacrylate)
N-HCA (n-Hexyl Cyanoacrylate)
Other Products
By Application Outlook (Revenue, USD Million, 2020-2034)
Arteriovenous Malformations (AVM)
Hypervascular Tumors
Peripheral Vasculature Hemorrhage
Other Applications
By End User Outlook (Revenue, USD Million, 2020-2034)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers (ASCs)
Other End Users
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Liquid Embolic Agent Market Insights
- 4.1. Liquid Embolic Agent Market - Market Snapshot
- 4.2. Liquid Embolic Agent Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Global Rise in Neurological and Cancer-Related Vascular Conditions
- 4.2.1.2. Government Healthcare Spending and Policies Promoting Advanced Therapies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Procedure Cost and Shortage of Skilled Interventional Radiologists
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Liquid Embolic Agent Market Trends
- 4.6. Value Chain Analysis
5. Global Liquid Embolic Agent Market, by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 5.3. Ethylene Vinyl Alcohol Copolymer (EVOH)
- 5.3.1. Global Liquid Embolic Agent Market, by Ethylene Vinyl Alcohol Copolymer (EVOH), by Region, 2020-2034 (USD Million)
- 5.4. Cyanoacrylates
- 5.4.1. Global Liquid Embolic Agent Market, by Cyanoacrylates, by Region, 2020-2034 (USD Million)
- 5.5. Other Products
- 5.5.1. Global Liquid Embolic Agent Market, by Other Products, by Region, 2020-2034 (USD Million)
6. Global Liquid Embolic Agent Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 6.3. Arteriovenous Malformations (AVM)
- 6.3.1. Global Liquid Embolic Agent Market, by Arteriovenous Malformations (AVM), by Region, 2020-2034 (USD Million)
- 6.4. Hypervascular Tumors
- 6.4.1. Global Liquid Embolic Agent Market, by Hypervascular Tumors, by Region, 2020-2034 (USD Million)
- 6.5. Peripheral Vasculature Hemorrhage
- 6.5.1. Global Liquid Embolic Agent Market, by Peripheral Vasculature Hemorrhage, by Region, 2020-2034 (USD Million)
- 6.6. Other Applications
- 6.6.1. Global Liquid Embolic Agent Market, by Other Applications, by Region, 2020-2034 (USD Million)
7. Global Liquid Embolic Agent Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 7.3. Hospitals
- 7.3.1. Global Liquid Embolic Agent Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 7.4. Specialty Clinics
- 7.4.1. Global Liquid Embolic Agent Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
- 7.5. Ambulatory Surgical Centers (ASCs)
- 7.5.1. Global Liquid Embolic Agent Market, by Ambulatory Surgical Centers (ASCs), by Region, 2020-2034 (USD Million)
- 7.6. Other End Users
- 7.6.1. Global Liquid Embolic Agent Market, by Other End Users, by Region, 2020-2034 (USD Million)
8. Global Liquid Embolic Agent Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Liquid Embolic Agent Market Assessment, By Geography, 2020-2034 (USD Million)
- 8.3. Liquid Embolic Agent Market - North America
- 8.3.1. North America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.3.2. North America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.3.3. North America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.3.4. Liquid Embolic Agent Market - U.S.
- 8.3.4.1. U.S.: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.3.4.2. U.S.: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.3.4.3. U.S.: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.3.5. Liquid Embolic Agent Market - Canada
- 8.3.5.1. Canada: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.3.5.2. Canada: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.3.5.3. Canada: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4. Liquid Embolic Agent Market - Europe
- 8.4.1. Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.3. Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.4. Liquid Embolic Agent Market - UK
- 8.4.4.1. UK: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.4.2. UK: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.4.3. UK: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.5. Liquid Embolic Agent Market - France
- 8.4.5.1. France: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.5.2. France: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.5.3. France: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.6. Liquid Embolic Agent Market - Germany
- 8.4.6.1. Germany: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.6.2. Germany: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.6.3. Germany: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.7. Liquid Embolic Agent Market - Italy
- 8.4.7.1. Italy: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.7.2. Italy: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.7.3. Italy: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.8. Liquid Embolic Agent Market - Spain
- 8.4.8.1. Spain: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.8.2. Spain: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.8.3. Spain: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.9. Liquid Embolic Agent Market - Netherlands
- 8.4.9.1. Netherlands: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.9.2. Netherlands: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.9.3. Netherlands: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.10. Liquid Embolic Agent Market - Russia
- 8.4.10.1. Russia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.10.2. Russia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.10.3. Russia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.11. Liquid Embolic Agent Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.11.2. Rest of Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.11.3. Rest of Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5. Liquid Embolic Agent Market - Asia Pacific
- 8.5.1. Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.4. Liquid Embolic Agent Market - China
- 8.5.4.1. China: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.4.2. China: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.4.3. China: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.5. Liquid Embolic Agent Market - India
- 8.5.5.1. India: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.5.2. India: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.5.3. India: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.6. Liquid Embolic Agent Market - Malaysia
- 8.5.6.1. Malaysia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.6.2. Malaysia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.6.3. Malaysia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.7. Liquid Embolic Agent Market - Japan
- 8.5.7.1. Japan: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.7.2. Japan: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.7.3. Japan: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.8. Liquid Embolic Agent Market - Indonesia
- 8.5.8.1. Indonesia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.8.2. Indonesia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.8.3. Indonesia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.9. Liquid Embolic Agent Market - South Korea
- 8.5.9.1. South Korea: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.9.2. South Korea: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.9.3. South Korea: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.10. Liquid Embolic Agent Market - Australia
- 8.5.10.1. Australia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.10.2. Australia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.10.3. Australia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.11. Liquid Embolic Agent Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.11.2. Rest of Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.11.3. Rest of Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6. Liquid Embolic Agent Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.4. Liquid Embolic Agent Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.6.4.2. Saudi Arabia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.6.4.3. Saudi Arabia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.5. Liquid Embolic Agent Market - UAE
- 8.6.5.1. UAE: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.6.5.2. UAE: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.6.5.3. UAE: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.6. Liquid Embolic Agent Market - Israel
- 8.6.6.1. Israel: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.6.6.2. Israel: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.6.6.3. Israel: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.7. Liquid Embolic Agent Market - South Africa
- 8.6.7.1. South Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.6.7.2. South Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.6.7.3. South Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.8. Liquid Embolic Agent Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.6.8.2. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.6.8.3. Rest of Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7. Liquid Embolic Agent Market - Latin America
- 8.7.1. Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.7.3. Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.4. Liquid Embolic Agent Market - Mexico
- 8.7.4.1. Mexico: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.7.4.2. Mexico: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.7.4.3. Mexico: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.5. Liquid Embolic Agent Market - Brazil
- 8.7.5.1. Brazil: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.7.5.2. Brazil: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.7.5.3. Brazil: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.6. Liquid Embolic Agent Market - Argentina
- 8.7.6.1. Argentina: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.7.6.2. Argentina: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.7.6.3. Argentina: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.7. Liquid Embolic Agent Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.7.7.2. Rest of Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.7.7.3. Rest of Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Arsenal Medical Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Balt Group
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Boston Scientific Corporation
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Chemence Medical Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Guerbet Group S.A.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Johnson & Johnson
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Medtronic plc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Meril Life Sciences Pvt. Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Merit Medical Systems Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Penumbra Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Stryker Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Terumo Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
